Telomir Pharmaceuticals (Telomir Pharmaceuticals) Price-to-Tangible-Book : 54.48 (As of May. 15, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-15), Telomir Pharmaceuticals's share price is $6.32. Telomir Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.12. Hence, Telomir Pharmaceuticals's Price to Tangible Book Ratio of today is 54.48.

The historical rank and industry rank for Telomir Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

TELO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0 Med: 0 Max: 57.41
Current: 52.67

During the past 3 years, Telomir Pharmaceuticals's highest Price to Tangible Book Ratio was 57.41. The lowest was 0.00. And the median was 0.00.

TELO's Price-to-Tangible-Book is ranked worse than
98.37% of 1230 companies
in the Biotechnology industry
Industry Median: 2.8 vs TELO: 52.67

A closely related ratio is called PB Ratio. As of today, Telomir Pharmaceuticals's share price is $6.32. Telomir Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.12. Hence, Telomir Pharmaceuticals's P/B Ratio of today is 54.48.

Telomir Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Telomir Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Price-to-Tangible-Book Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Telomir Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Telomir Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telomir Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telomir Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Telomir Pharmaceuticals's Price-to-Tangible-Book falls into.

Telomir Pharmaceuticals Price-to-Tangible-Book Calculation

Telomir Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	6.32	/	0.116
	=	54.48

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Telomir Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024